Struggling biotech’s revenue and profit plunged. Wall Street saw something to cheer. – []

Novavax’s stock surged 30 percent Tuesday, it’s biggest one-day gain in more than two years as the struggling vaccine maker pledged to slash costs and disclosed promising results of vaccines in development. Δείτε περισσότερα: The Washington Post


ΕΝΙΔΕΑ Λογότυπο
Μέλος της Διεθνούς Συνομοσπονδίας Ιδιωτικών Εταιρειών Απασχόλησης -World Employment Confederation- και της αντίστοιχης Ευρωπαϊκής Συνομοσπονδίας, World Employment Confederation Europe.